opdyta 40mg injection

Therapeutic Class: ANTI NEOPLASTICS
Action Class: Programmed Cell Death 1 (PD-1) Checkpoint Inhibitors
Chemical Class: Monoclonal antibody (mAb)
Habit Forming: No

USES
Non-small cell lung cancer
Kidney cancer
Head and neck cancer
Melanoma
Hodgkinâ€™s disease

SIDE EFFECTS
Rash
Weakness
Headache
Fever
Musculoskeletal (bone, muscle or joint) pain
Back pain
Stomach pain
Nausea
Itching
Constipation
Diarrhea
Upper respiratory tract infection
Decreased appetite
Breathlessness
Cough

